PASSAGE BIO RECEIVES FDA CLEARANCE OF IND APPLICATION FOR PBML04 FOR TREATMENT OF METACHROMATIC LEUKODYSTROPHY

Passage Bio: “We are thrilled to have received IND clearance for our program in metachromatic leukodystrophy, marking our fourth IND clearance as a company and our third pediatric lysosomal storage disorder program to reach clinical development”

To read the full press release, visit: Press Release 08.06.22